AOD-9604
Clinically Shown to Reduce Abdominal Fat
⭐⭐⭐⭐⭐Stimulates Fat Breakdown
Potential Benefits of AOD-9604
Targeted Fat-Metabolism Support
A synthetic fragment of human growth hormone (hGH 177-191) studied for its role in lipolysis and adipose-tissue metabolism.
Program-Friendly
Often incorporated alongside nutrition, sleep, and training plans as part of a comprehensive body-composition program.
Convenient Administration
Clinic protocols typically use small subcutaneous injections with flexible scheduling.
Contraindications & Precautions
Contraindications
- Known hypersensitivity to AOD-9604 or formulation components
- Pregnancy or breastfeeding
- Active malignancy (or history of cancer without verified remission)
Use with Caution
- Diabetes or impaired glucose tolerance — monitor glucose/A1c as directed
- Significant cardiovascular, hepatic, or renal disease — specialist oversight
- Concurrent use with other weight-management drugs or GH-axis therapies
- Allergy history; prior injection-site reactions
Outcomes, Dosing & Side Effects
Reported/Program Outcomes
- Support for fat-loss programs when paired with diet and activity
- Some clients report reduced cravings or improved adherence
- Expectations should be conservative; individual responses vary
Dosing & Administration
- Route: Subcutaneous injection
- Frequency: Clinic protocols vary (commonly daily; 5–7 days/week)
- Timing: Morning or evening per prescriber/program
- Sites: Abdomen, thigh, or upper arm — rotate sites
Exact dose and schedule are individualized and determined by your licensed provider. Follow clinic instructions and monitoring plans.
Side Effects — Common
- Injection-site redness, itching, or bruising
- Headache, nausea, indigestion
- Dizziness, flushing, mild fatigue
- Sleep changes or vivid dreams (occasionally reported)
Side Effects — Serious/Rare
- Allergic reactions (rash, swelling, breathing difficulty) — seek care
- Marked or persistent palpitations, chest pain, or severe dizziness — evaluate promptly
- Worsening glucose control — contact your provider
Why Choose AOD-9604?
AOD-9604 is a laboratory-made peptide corresponding to the C-terminal region of hGH (amino acids 177–191). It has been explored for its potential to influence fat-metabolism pathways while avoiding traditional GH replacement.
“With structured nutrition and routine exercise, I noticed steadier progress around my midsection over two months. The simple injections were easy to fit into my week.” — Keisha W.
Proposed Mechanism
- hGH-Fragment Activity: Peptide derived from the lipolytic region of growth hormone (177–191)
- Lipolysis/Lipogenesis Balance: Preclinical and early human work suggests effects on fat breakdown and storage pathways
- No GH Replacement: Does not function as growth hormone; programs do not substitute for GH therapy
- Administration: Subcutaneous micro-dose protocols under clinician supervision
Educational content only. AOD-9604 is investigational and not FDA-approved. Programs should be overseen by a licensed medical professional and tailored to the individual.